22nd Century Group Archives

StaffNovember 27, 2023

The Daily Hit is a recap of the top financial news stories for Nov. 27, 2023. On the Site Cronos Sells Peace Naturals Campus for C$23 Million Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is selling its Peace Naturals Campus to Future Farmco Canada Inc. for C$23 million in cash. However, Cronos won’t be leaving […]

Adam JacksonNovember 27, 2023

Specialty Acquisition Corp. already has connections to GVB's current employees.

StaffNovember 6, 2023

The Daily Hit is a recap of the top financial news stories for Nov. 6, 2023. On the Site Florida Medical Cannabis Company Suing State Over $1.3M License Fee One of Florida’s 24 medical marijuana businesses has filed suit against the state over its whopping $1.33 million biennial licensing fee, which was raised in December […]

John SchroyerNovember 6, 2023

The company chalked up the dip to challenges with both its tobacco and hemp divisions.

Adam JacksonAugust 14, 2023

The firm still had to lower its 2023 revenue outlook.

StaffJuly 26, 2023

The Daily Hit is a recap of the top financial news stories for July 26, 2023. On the Site Tilray Brands Stock Jumps on $30M Revenue Beat Tilray Brands Inc. (Nasdaq: TLRY) (TSX: TLRY) stock was up more than 20% after the cannabis CPG giant surprised investors with boosts in revenue and adjusted EBIDTA, while […]

Debra BorchardtJuly 26, 2023

Tobacco and cannabis company 22nd Century Group, Inc. (Nasdaq: XXII) reported that John Miller, who leads the tobacco business unit, has been appointed as interim Chief Executive Officer. James A. Mish, who has served as CEO since June 2020, will continue to serve as a member of the Board of Directors. In addition to the […]

StaffJune 20, 2023

The Daily Hit is a recap of the top financial news stories for June 20, 2023. On the Site Herbl Employees Say Goodbye Amid Reports the Company Shut Down While Herbl has yet to confirm the news, it seems the big California distributor has turned out the lights. There had been rumblings for days that […]

Adam JacksonJune 20, 2023

A spokesperson for the company said that the offering is not a result of the SEC settlement.

StaffMay 8, 2020

Arena Pharmaceuticals Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2020. Revenues for the first quarter totaled $0.3 million compared to $801.1 million in the first quarter of 2019. This decrease was driven by the $800.0 million upfront payment from the United […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: 22nd Century Group

The Daily Hit: November 27, 2023

22nd Century Group to Sell Hemp Business to SPAC

The Daily Hit: November 6, 2023

22nd Century Group Revenue Dips in Q3

22nd Century Gets Lift From Cannabis Division in Q2

The Daily Hit: July 26, 2023

22nd Century Group Names New CEO

Daily Hit: June 20, 2023

22nd Century Group Eyes $5.3M Stock Offering Amid SEC Settlement

Earnings Roundup: Arena Pharmaceuticals, CV Sciences, 22nd Century

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox